Feed & Additive Magazine Issue 22 November 2022

NEWS FEED & ADDITIVE MAGAZINE November 2022 7 Calysseo, a joint venture between worldwide animal nutrition leader Adisseo and protein innovator Calysta, has switched on its first industrial-scale alternative protein facility to produce FeedKind® in China. The world’s first industrial-scale facility to produce FeedKind®, a protein ingredient that needs no animal or plant matter to produce, has switched on. Calysseo, a joint venture between Adisseo and Calysta, will initially produce 20,000 tonnes of protein per year from the facility in Chongqing, China. With startup operations complete, the fermenter will become world’s largest single protein production facility. First deliveries, of FeedKind Aqua®, will be made to customers soon, making it the first alternative fermented protein to address the sector at scale. “Food security has increasingly come under the spotlight in recent months, but we are now entering a new era of sustainable food production. Calysseo brings to the market a new way of making high-quality protein – and does so using a naturally-occurring microbe that makes the resulting protein non-GMO, something that is increasingly demanded through the supply chain," said Jean-Marc Dublanc, CEO of Adisseo. “We have a long-running commitment to improving the security and sustainability of the feed ingredient market and Calysseo fulfils a significant part of that pledge. We will provide Chinese customers with a reliable, domestically available supply of protein that meets their specific needs; produced in China for China. We are looking forward to working with our customers as they begin to integrate this product into their supply chains.” The Chongqing facility will produce FeedKind Aqua® for use in fish farming, allowing farmers to replace fishmeal and soy with a high-quality ingredient that needs no arable land and no plant matter. Initially, production will be available for use in China, the world’s largest aquaculture market. World’s first industrial-scale alternative protein facility switches on allow multiple studies to be conducted in conditions that mimic commercial production environments. Skretting AI Guayas Research Station will study all stages of shrimp production – from larvae through to harvest size animals. Simulations and evaluations will include health and welfare parameters, as well as growth and feed efficiency. Another key focus area is the digestibility of new and existing feed ingredients and balanced diets. For this purpose, sophisticated biotechnologies will be implemented and further developed. The new station’s team will have the on-hand support of Skretting’s global network of scientific experts and its overarching global research units. Together, they will help Skretting Al Guayas Research Station better understand how shrimp can be helped to grow faster and larger and be more resilient to disease and environmental challenges so that innovations can be developed that turn these crucial findings into practical industry solutions.

RkJQdWJsaXNoZXIy MTUxNjkxNQ==